Desjardins Issues Pessimistic Forecast for Kits Eyecare (TSE:KITS) Stock Price

Kits Eyecare (TSE:KITS) had its price objective reduced by equities research analysts at Desjardins from C$25.00 to C$23.00 in a research note issued on Thursday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Desjardins’ price objective points to a potential upside of 96.58% from the stock’s current price.

Separately, ATB Cormark Capital Markets cut their price target on Kits Eyecare from C$20.00 to C$16.75 and set a “speculative buy” rating for the company in a research note on Thursday. Four research analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of C$20.69.

Kits Eyecare Price Performance

Shares of Kits Eyecare stock opened at C$11.70 on Thursday. Kits Eyecare has a one year low of C$11.12 and a one year high of C$22.56. The stock has a market capitalization of C$397.68 million, a P/E ratio of 130.00 and a beta of 0.46.

Kits Eyecare (TSE:KITS) last issued its earnings results on Wednesday, May 6th. The company reported C$0.06 EPS for the quarter. The firm had revenue of C$57.47 million during the quarter.

Kits Eyecare Company Profile

KITS (TSX: KITS) is one of the world’s fastest growing eyecare providers, offering high-quality, affordable prescription glasses and contact lenses through its vertically integrated digital platform. With advanced in-house lens manufacturing, an industry-leading digital fit experience powered by OpticianAI, and thousands of 5-star customer reviews, KITS is redefining how Canadians experience eyecare. Designed in Canada. Delivered worldwide.